Closed call · historical reference
Scope:Specific challenge In view of the current epidemic, the WHO has identified the progression of vaccine candidates currently in development as an urgent public health need. Because Ebola vaccines are recombinant adenovirus or other viral-based vaccines and need to be produced in facilities meet…
Topics
Partner types
business, research_center, university